Loftex and GHCL are first Applied DNA customers to verify recycled bottle for consumer goods, providing trust through supply chain transparency

Celebrating America Recycles Day, November 15, Applied DNA Sciences, (Applied DNA) expands its initiative targeting recycled components across a wide variety of industries, including home goods, apparel, footwear, automotive and other industrial products. Applied DNA’s proprietary technology enables customers to identify and verify the origin of components used every day, and track them throughout the global supply chain. Its first customer, Loftex, uses Applied DNA’s CertainT® supply chain platform ensuring that the plastics used in towels are truly 100 percent recycled polyethylene terephthalate (rPET post-consumer) from recycled plastic bottles.

In addition to Loftex, Applied DNA has signed an agreement with GHCL, a global manufacturer of home textiles. GHCL will use Applied DNA’s CertainT platform to tag, test and track PET and recycled PET blended bed linens, pillowcases, and shams.

“Consumers are becoming increasingly concerned with protecting the environment as well as demanding more information about the impact, origin, and authenticity of their products,” said Dr. James A. Hayward, president and CEO of Applied DNA Sciences. “Our solution enables brands to provide consumers with certainty in knowing their recycled products are forensically authenticated from source to shelf.”

It takes 700 years for plastic bottles in landfills to start to decompose and currently less than 10 percent of plastic bottles in the U.S. are recycled. For every pound of rPET used, energy consumption is reduced by 84 percent and greenhouse gases are reduced by 71 percent. rPET has become an environmentally-sound solution for textile manufacturers.

“True sustainability requires pioneering business models and entrepreneurial partners,” added Hayward. “Platforms like CertainT helps companies produce recycled, innovative products utilizing an efficient and trusted traceability system with a fair return. Traceability and transparency, combined with trust in supply chains builds consumer confidence, it’s appealing to both brands and consumers.”

For more information, please contact us
investor contact: Sanjay Hurry, 212-838-3777shurry@lhai.com
media contact: Angie Mathews, 781-639-4924angie@cgprpublicrelations.com
program contact: MeiLin Wan, 631-240-8849meilin.wan@adnas.com
web: adnas.comtwitter: @APDN
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.
We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.
Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017  which are available at www.sec.gov. APDN , undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.